Stability of fluconazole in injectable solutions

A K Hunt-Fugate1, C K Hennessey, C M Kazarian

  • 1Department of Pharmacy Services, Sparrow Hospital, Lansing, MI 48912.

American Journal of Hospital Pharmacy
|June 1, 1993
PubMed

Insights

Fluconazole injection stability was assessed in common IV solutions. It remained stable for 72 hours in dextrose with potassium chloride or theophylline, but only 24 hours in others.

Area of Science:

  • Pharmaceutical Sciences
  • Clinical Pharmacy
  • Drug Stability

Background:

  • Intravenous fluconazole is widely used for fungal infections.
  • Understanding its stability in various intravenous admixtures is crucial for safe administration.
  • Limited data exists on fluconazole stability in complex injectable solutions.

Purpose of the Study:

  • To evaluate the stability of fluconazole in several common injectable solutions at 25°C for up to 72 hours.
  • To determine the compatibility of fluconazole with dextrose, lactated Ringer's, potassium chloride, heparin, theophylline, and morphine sulfate admixtures.

Main Methods:

  • Fluconazole (2 mg/mL) was admixed with various injectable solutions in a 1:1 ratio.
  • Samples were analyzed for fluconazole concentration using stability-indicating gas chromatography at specified time points (0-72 hours).
  • The study focused solely on fluconazole stability, not the stability of other components.

Main Results:

  • Fluconazole demonstrated stability for 72 hours in 5% dextrose injection with potassium chloride and with theophylline.
  • Fluconazole exhibited stability for 24 hours in 5% dextrose injection, lactated Ringer's injection, and admixtures with heparin or morphine sulfate.
  • The stability of other components in the admixtures was not assessed.

Conclusions:

  • Fluconazole is stable in specific intravenous admixtures (potassium chloride/dextrose, theophylline/dextrose) for extended periods (72 hours).
  • Compatibility is limited to 24 hours in other tested injectable solutions, necessitating careful preparation and administration protocols.
  • Further studies are needed to assess the stability of other components in these admixtures.

Related Concept Videos

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Drug Product Stability01:16

Drug Product Stability

The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...